LONDON, April 29 (Reuters) – British drugmaker GSK reported first-quarter profit above analysts’ expectations on Wednesday, helped by strong sales of its respiratory and other general medicines.
GSK reported core earnings per share of 46.5 pence for the three months ended March 31, compared with analyst expectations of 43.3 pence, according to company-provided consensus estimates.
(Reporting by Bhanvi Satija in London; Editing by Andrew Heavens)
